Advanced Biomed (ADVB) Equity Average (2024 - 2026)

Advanced Biomed has disclosed Equity Average across 3 years of filings, most recently posting $9.3 million for Q1 2026.

• Equity Average for Q1 2026 came in at $9.3 million, up 293.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.3 million (up 293.6% YoY), and the FY2025 annual result was $2.6 million, changed N/A from the prior year.
• Equity Average came in at $9.3 million for Q1 2026 at Advanced Biomed, up from $6.2 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $9.3 million in Q1 2026 to a low of -$150478.0 in Q1 2024.
• The 3-year median for Equity Average is $2.4 million (2025), against an average of $3.1 million.
• Peak annual rise in Equity Average reached 1677.91% in 2025, while the deepest fall reached 135.09% in 2025.
• Advanced Biomed's Equity Average stood at $856431.0 in 2024, then jumped by 628.94% to $6.2 million in 2025, then soared by 49.7% to $9.3 million in 2026.
• The last three Equity Average figures came in at $9.3 million (Q1 2026), $6.2 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.